DHR vs JPM: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and JPMorgan Chase & Co. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
JPMorgan Chase & Co. · Financial Services
$316.99
+139.7% upside to fair value
Grade C
High Quality
QuantHub Verdict
JPM has more upside to fair value
(+139.7%).
JPM trades at a lower forward P/E
(15.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
JPM |
| Current Price |
$174.04 |
$316.99 |
| Fair Value Estimate |
$197.01 |
$759.82 |
| Upside to Fair Value |
+13.2%
|
+139.7%
|
| Market Cap |
$123.2B |
$854.9B |
| Forward P/E |
33.4x
|
15.0x
|
| EV / EBITDA |
20.3x
|
21.8x
|
| Price / Sales |
5.0x
|
3.0x
|
| Price / FCF |
23.3x
|
8.5x
|
| Revenue Growth YoY |
+3.7%
|
+6.9%
|
| Gross Margin |
60.7%
|
60.9%
|
| Operating Margin |
21.0%
|
26.2%
|
| Return on Equity |
7.1%
|
16.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
11.79%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
JPMorgan Chase & Co. is a leading diversified financial services firm with a strong competitive moat driven by its scale, diversified revenue streams, and long-tenured leadership. The company operates across four main segments: Commercial & Investment Bank, Consumer & Community Banking, Asset & Wealth Management, and Corporate, generating $279.75 billion in revenue in fiscal 2025. Its durable com…
Accumulation Zones
| Metric |
DHR |
JPM |
| Zone Low |
$147.76 |
$569.87 |
| Zone High |
$167.46 |
$645.85 |
| In Buy Zone? |
No
|
Yes
|